DK1176192T3 - Helicobacter felis-vaccine - Google Patents
Helicobacter felis-vaccineInfo
- Publication number
- DK1176192T3 DK1176192T3 DK01202666T DK01202666T DK1176192T3 DK 1176192 T3 DK1176192 T3 DK 1176192T3 DK 01202666 T DK01202666 T DK 01202666T DK 01202666 T DK01202666 T DK 01202666T DK 1176192 T3 DK1176192 T3 DK 1176192T3
- Authority
- DK
- Denmark
- Prior art keywords
- subunit polypeptides
- helicobacter felis
- nucleic acid
- acid sequences
- vaccines
- Prior art date
Links
- 241000590017 Helicobacter felis Species 0.000 title abstract 5
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 6
- 150000007523 nucleic acids Chemical group 0.000 abstract 4
- 108020004414 DNA Proteins 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 108010046334 Urease Proteins 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00202565 | 2000-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1176192T3 true DK1176192T3 (da) | 2004-02-02 |
Family
ID=8171823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01202666T DK1176192T3 (da) | 2000-07-17 | 2001-07-11 | Helicobacter felis-vaccine |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7514547B2 (pt) |
| EP (1) | EP1176192B1 (pt) |
| JP (1) | JP2002355054A (pt) |
| AT (1) | ATE251215T1 (pt) |
| AU (1) | AU782172B2 (pt) |
| CA (1) | CA2351110A1 (pt) |
| DE (1) | DE60100879T2 (pt) |
| DK (1) | DK1176192T3 (pt) |
| ES (1) | ES2208519T3 (pt) |
| PT (1) | PT1176192E (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102078622A (zh) * | 2004-08-13 | 2011-06-01 | 巴里.J.马沙尔 | 细菌递送系统 |
| US8029777B2 (en) | 2004-08-13 | 2011-10-04 | Marshall Barry J | Helicobacter system and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6290962B1 (en) * | 1992-11-03 | 2001-09-18 | Oravax, Inc. | Urease-based vaccine and treatment for helicobacter infection |
| US5843460A (en) * | 1993-05-19 | 1998-12-01 | Institut Pasteur | Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides |
| WO1995014093A1 (en) * | 1993-05-19 | 1995-05-26 | Institut Pasteur | Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| US5610060A (en) * | 1994-06-24 | 1997-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | Isolated Helicobacter hepaticus |
| KR19990007828A (ko) * | 1995-04-21 | 1999-01-25 | 피터 터비 | 헬리코박터 감염 방어 항원 |
| JP3007037B2 (ja) * | 1995-07-19 | 2000-02-07 | 秀実 高橋 | ヘリコバクター・ピロリ菌ウレアーゼ蛋白由来の人工抗原及びその人工抗原によって誘発された抗体 |
| GB2307987A (en) * | 1995-12-06 | 1997-06-11 | Univ Manchester | Epitopes of the urease of Helicobacter pylori as dignostic agents; pharmaceuticals comprising such epitopes or the antibodies thereto |
| JP3430853B2 (ja) * | 1997-04-11 | 2003-07-28 | 株式会社ゲン・コーポレーション | 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤 |
| US20030158396A1 (en) * | 1997-07-29 | 2003-08-21 | Harold Kleanthous | Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome |
| US5985631A (en) * | 1997-09-12 | 1999-11-16 | Oravax-Merieux Co. | Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease |
| WO2001083531A1 (en) * | 2000-04-27 | 2001-11-08 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for identifying helicobacter antigens |
-
2001
- 2001-07-03 CA CA002351110A patent/CA2351110A1/en not_active Abandoned
- 2001-07-11 ES ES01202666T patent/ES2208519T3/es not_active Expired - Lifetime
- 2001-07-11 DE DE60100879T patent/DE60100879T2/de not_active Expired - Fee Related
- 2001-07-11 AT AT01202666T patent/ATE251215T1/de not_active IP Right Cessation
- 2001-07-11 DK DK01202666T patent/DK1176192T3/da active
- 2001-07-11 AU AU54321/01A patent/AU782172B2/en not_active Ceased
- 2001-07-11 PT PT01202666T patent/PT1176192E/pt unknown
- 2001-07-11 EP EP01202666A patent/EP1176192B1/en not_active Expired - Lifetime
- 2001-07-13 US US09/904,994 patent/US7514547B2/en not_active Expired - Fee Related
- 2001-07-16 JP JP2001214711A patent/JP2002355054A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1176192A3 (en) | 2002-02-06 |
| AU5432101A (en) | 2002-01-24 |
| US7514547B2 (en) | 2009-04-07 |
| CA2351110A1 (en) | 2002-01-17 |
| US20040005325A1 (en) | 2004-01-08 |
| ES2208519T3 (es) | 2004-06-16 |
| PT1176192E (pt) | 2004-01-30 |
| EP1176192A2 (en) | 2002-01-30 |
| ATE251215T1 (de) | 2003-10-15 |
| JP2002355054A (ja) | 2002-12-10 |
| AU782172B2 (en) | 2005-07-07 |
| EP1176192B1 (en) | 2003-10-01 |
| DE60100879D1 (de) | 2003-11-06 |
| DE60100879T2 (de) | 2004-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122505T1 (el) | Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn | |
| DK1219711T3 (da) | Lawsonia Intracellularis vaccine | |
| EA200700849A1 (ru) | Первичная/бустерная противомалярийная вакцина | |
| DK0942983T3 (da) | Streptococcus pneumoniae-antigener og -vacciner | |
| ATE470673T1 (de) | Impfstoffe mit lawsoniaintrazellularis- untereinheit | |
| NZ500540A (en) | Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae | |
| ATE450545T1 (de) | Impfstoff mit lawsonia intracellularis- untereinheit | |
| DE60100879D1 (de) | Helicobacter felis Impfstoff | |
| ZA200602107B (en) | Piroplasmid vaccine | |
| WO2004007726A3 (en) | Brachyspira hyodysenteriae vaccine | |
| TW200801034A (en) | Novel sea lice vaccine | |
| DE60239753D1 (de) | Impfstoff gegen infektiöses lachsanämievirus | |
| DK0995799T3 (da) | Coccidiose-vacciner | |
| WO2002051237A3 (en) | Helicobacter proteins, nucleic acids and uses thereof | |
| ATE374622T1 (de) | Genetische impstoffe mit adjuvans | |
| WO2004024769A3 (en) | Ostertagia vaccine | |
| DE60025522D1 (de) | Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung | |
| ATE450546T1 (de) | Impfstoffe mit ornithobakterium rhinotracheale- untereinheit | |
| TH62170A (th) | วัคซีนเชื้อก่อโรค Lawsonia intracellularis | |
| ATE460945T1 (de) | Genetische adjuvanz-impfstoffe |